News
-
-
PRESS RELEASE
EQS-Adhoc: STRATEC REPORTS PRELIMINARY BUSINESS RESULTS FOR 2024, PROVIDES GUIDANCE FOR 2025, AND POSTPONES 2024 ANNUAL REPORT
STRATEC SE reports preliminary business results for 2024, provides guidance for 2025, and postpones 2024 annual report. Adjustments in accounting method are expected to have a positive effect on 2024 earnings -
PRESS RELEASE
H2APEX receives shareholder loan and plans capital increase for further expansion of its hydrogen production capacities
H2APEX secures EUR 35M for hydrogen production expansion; plans EUR 30M capital increase, signs loan agreement and comfort letter, targets industrial-scale growth in Germany -
-
-
-
-
PRESS RELEASE
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
AB Science's AB8939 granted orphan drug designation by EMA in EU for treating acute myeloid leukemia, showing significant benefit over current therapies. Preclinical data reveals efficacy and safety -
-
REGULATED PRESS RELEASE
Derichebourg announces its financial calendar for 2024/2025 financial year
Derichebourg announces its financial calendar for 2024/2025 financial year. Events include half-year and full-year results, AGM dates. Derichebourg Group is a leader in metal recycling and environmental services